These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Chua CC; Rahimi N; Forsten-Williams K; Nugent MA Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627 [TBL] [Abstract][Full Text] [Related]
7. [Activation of the cell proliferation program by acidic fibroblast growth factor (aFGF)]. Wiedłocha A Postepy Hig Med Dosw; 1999; 53(2):277-89. PubMed ID: 10355293 [TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR. Wang X; Weng LP; Yu Q Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386 [TBL] [Abstract][Full Text] [Related]
9. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling. Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339 [TBL] [Abstract][Full Text] [Related]
10. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Fujii T; Yonemitsu Y; Onimaru M; Tanii M; Nakano T; Egashira K; Takehara T; Inoue M; Hasegawa M; Kuwano H; Sueishi K Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2483-9. PubMed ID: 16960104 [TBL] [Abstract][Full Text] [Related]
11. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955 [TBL] [Abstract][Full Text] [Related]
12. Retrograde transport of acidic fibroblast growth factor as a part of the growth factor signaling. Wiedłocha A Arch Immunol Ther Exp (Warsz); 1996; 44(4):201-7. PubMed ID: 9017159 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972 [TBL] [Abstract][Full Text] [Related]
14. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail. Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. Friesel RE; Maciag T FASEB J; 1995 Jul; 9(10):919-25. PubMed ID: 7542215 [TBL] [Abstract][Full Text] [Related]
16. Serum-starvation induces the extracellular appearance of FGF-1. Shin JT; Opalenik SR; Wehby JN; Mahesh VK; Jackson A; Tarantini F; Maciag T; Thompson JA Biochim Biophys Acta; 1996 Jun; 1312(1):27-38. PubMed ID: 8679713 [TBL] [Abstract][Full Text] [Related]
17. The unconventional secretory machinery of fibroblast growth factor 2. Nickel W Traffic; 2011 Jul; 12(7):799-805. PubMed ID: 21585635 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Rusnati M; Presta M Curr Pharm Des; 2007; 13(20):2025-44. PubMed ID: 17627537 [TBL] [Abstract][Full Text] [Related]
19. FGF-1: from biology through engineering to potential medical applications. Zakrzewska M; Marcinkowska E; Wiedlocha A Crit Rev Clin Lab Sci; 2008; 45(1):91-135. PubMed ID: 18293181 [TBL] [Abstract][Full Text] [Related]